Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Times Interest Earned (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Times Interest Earned for 6 consecutive years, with $7.72 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 1633.09% year-over-year to $7.72, compared with a TTM value of -$85.2 through Dec 2025, down 2274.9%, and an annual FY2025 reading of -$85.2, down 2274.9% over the prior year.
  • Times Interest Earned was $7.72 for Q4 2025 at Cytek Biosciences, up from -$18.61 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $8.8 in Q2 2021 and bottomed at -$63.63 in Q2 2024.
  • Average Times Interest Earned over 5 years is -$12.3, with a median of -$2.69 recorded in 2022.
  • The sharpest move saw Times Interest Earned tumbled 1520.43% in 2023, then surged 1633.09% in 2025.
  • Year by year, Times Interest Earned stood at $2.43 in 2021, then tumbled by 94.98% to $0.12 in 2022, then plummeted by 384.38% to -$0.35 in 2023, then crashed by 44.74% to -$0.5 in 2024, then soared by 1633.09% to $7.72 in 2025.
  • Business Quant data shows Times Interest Earned for CTKB at $7.72 in Q4 2025, -$18.61 in Q3 2025, and -$25.66 in Q2 2025.